Immune cells in pancreatic cancer: Joining the dark side

OncoImmunology

Volumn 3, Issue 6, 2014, Pages

  Zhang, Yaqing ^a   McAllister, Florencia ^b   di Magliano, Marina Pasca ^a,c,d,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Program in Cell and Molecular Biology   (United States)

^d Program in Cellular and Molecular Biology ^*  (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CD4 T cells; CD8 T cells; Il 17; Kras; Mouse model; Pancreatic cancer; Regulatory T cells

Indexed keywords

CD3 ANTIBODY; CERULETIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME B; INTERLEUKIN 6; MONOCLONAL ANTIBODY CD28; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; IMMUNE DEFICIENCY; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE MODEL; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS CANCER; PANCREATITIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T CELL DEPLETION; TH17 CELL; TUMOR MICROENVIRONMENT;

EID: 84906516245     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.29125     Document Type: Article

References (11)

1. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014 [cited 2014 June 5]. Available from: http:// www.cancer.org/research/cancerfactsstatistics / cancerfactsfigures2014/index
2. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437-50; PMID:14706336; http://dx.doi.org/10.1016/S1535-6108(03)00309-X
3. Morris JP 4th, Cano DA, Sekine S, Wang SC, Hebrok M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 2010; 120:508-20; PMID:20071774; http://dx.doi.org/10.1172/ JCI40045
4. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67:9518-27; PMID:17909062; http://dx.doi.org/10.1158/0008-5472.CAN-07-0175
5. Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, di Magliano MP. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res 2014; 2.
6. McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, et al. Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia. Cancer Cell 2014; 25:621-37; PMID:24823639; http://dx.doi. org/10.1016/j.ccr.2014.03.014
7. Collins MA, Bednar F, Zhang Y, Brisset JC, Galbán S, Galbán CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 2012; 122:639-53; PMID:22232209; http://dx.doi.org/10.1172/ JCI59227
8. Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 2013; 73:6359-74; PMID:24097820; http:// dx.doi.org/10.1158/0008-5472.CAN-13-1558-T
9. Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S, et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19:456-69; PMID:21481788; http://dx.doi.org/10.1016/j. ccr.2011.03.009
10. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21:836-47; PMID:22698407; http://dx.doi.org/10.1016/j. ccr.2012.04.024
11. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21:822-35; PMID:22698406; http://dx.doi.org/10.1016/j.ccr.2012.04.025